90.8
Crescent Biopharma Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
50.7
FY23:
43.8
FY24:
34.8
FY25:
237
(positive)
Change from FY21 to FY25
millions USD
FY21:
3.56
FY22:
1.10
FY23:
1.53
FY24:
0.81
FY25:
3.64
Total assets
Change from FY21 to FY25
millions USD
FY21:
94.3
FY22:
51.8
FY23:
45.3
FY24:
35.6
FY25:
240
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
11.8
FY22:
8.88
FY23:
6.84
FY24:
9.61
FY25:
36.1
(negative)
Change from FY21 to FY25
millions USD
FY21:
0.92
FY22:
0
FY23:
0.07
FY24:
37.5
FY25:
1.21
(positive)
Change from FY21 to FY25
millions USD
FY21:
81.6
FY22:
42.9
FY23:
38.4
FY24:
−15.5
FY25:
203
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
94.3
FY22:
51.8
FY23:
45.3
FY24:
–
FY25:
240
All amounts in millions USD